Back to Search
Start Over
Prognostic factors related to post-platinum atezolizumab for relapsed metastatic urothelial cancer (mUC) from the SAUL study
- Authors :
- Bamias, A. Merseburger, A. Loriot, Y. James, N. Choy, E. and Gauna, D. Castellano Lopez-Rios, F. Calabro, F. Kramer, M. W. de Velasco, G. Zakopoulou, R. Tzannis, K. and Sternberg, C. N.
- Publication Year :
- 2020
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od......2127..5ba593980a42c6c66d3cb48c3772c625